Med Ed Report briefs

Share this article:
Sen. Charles Grassley (R-IA) sent letters to the AMA, American Cancer Society and 31 other disease and medical advocacy organizations asking them to provide details about the amount of money that they receive from drug and device makers. Grassley told the New York Times that societies, due to their influence on public policy, make a “strong case for disclosure.”

The Canadian Medical Association (CMA) is taking heat over an online CME series funded by a $780,000 grant from Pfizer Canada. Two Pfizer Canada members are to sit on the board overseeing the program, the Globe and Mail reported. The CMA said the series meets all ethical standards for physicians and industry.

Pri-Med said it issued the 15 millionth CME credit for physician participation in one of its educational activities. Pri-Med also said it will deliver over 85 live activities in 49 US cities, plus over 600 online activities on Pri-Med.com for 2010.

Northwestern University Feinberg School of Medicine agreed to disclose financial relationships between faculty and drug and device makers on its website. Detailed faculty profiles now include external professional and industry relationships for about 2,000 full- and part-time faculty, including physicians and scientists.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?